The association between lower EGF and higher CCL2 mRNA levels in the kidney tubulointerstitium suggests that the molecular pathways represented by these 2 biomarkers are simultaneously and actively involved in CKD pathogenesis. The gene discussed is EGF; the disease is chronic kidney disease.